$7.01
3.97% day before yesterday
Nasdaq, Jan 02, 10:00 pm CET
ISIN
CA35954B2066
Symbol
QNTM

FSD Pharma Inc Stock price

$7.01
-2.69 27.73% 1M
-12.15 63.41% 6M
-0.29 3.97% YTD
+2.93 71.81% 1Y
-44.24 86.32% 3Y
-100.24 93.46% 5Y
-1,119.19 99.38% 10Y
-1,119.19 99.38% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
-0.29 3.97%
ISIN
CA35954B2066
Symbol
QNTM
Industry

Key metrics

Basic
Market capitalization
$29.4m
Enterprise Value
$30.1m
Net debt
$740.0k
Cash
$1.5m
Shares outstanding
3.5m
Valuation (TTM | estimate)
P/E
negative | -
P/S
- | 9.0
EV/Sales
- | 8.8
EV/FCF
negative
P/B
7.8
Financial Health
Equity Ratio
-
Return on Equity
-
ROCE
-910.9%
ROIC
-
Debt/Equity
0.6
Financials (TTM | estimate)
Revenue
$0.0 | $8.7m
EBITDA
$-18.2m | -
EBIT
$-18.7m | -
Net Income
$-26.6m | -
Free Cash Flow
$-10.5m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-80.6% | -
EBIT
-76.3% | -
Net Income
-223.1% | -
Free Cash Flow
-104.5%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-8.8
FCF per Share
$-3.0
Short interest
1.8%
Employees
-
Rev per Employee
-
Show more

Is FSD Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

FSD Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a FSD Pharma Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a FSD Pharma Inc forecast:

Buy
86%
Hold
14%

Financial data from FSD Pharma Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 11 11
21% 21%
-
- Research and Development Expense 7.22 7.22
581% 581%
-
-18 -18
81% 81%
-
- Depreciation and Amortization 0.50 0.50
6% 6%
-
EBIT (Operating Income) EBIT -19 -19
76% 76%
-
Net Profit -27 -27
223% 223%
-

In millions USD.

Don't miss a Thing! We will send you all news about FSD Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

FSD Pharma Inc Stock News

Neutral
GlobeNewsWire
11 days ago
Studies Will Support Investigational New Drug Application (IND) with the US FDA, Including Design of Phase 2 Trial Studies Will Support Investigational New Drug Application (IND) with the US FDA, Including Design of Phase 2 Trial
Neutral
GlobeNewsWire
about one month ago
TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), is pleased to announce that national television network CTV News' flagship investigative program W5 has aired Part 2 of a three-part series about Quantum Biopharma and the company's allegations of stock market manipulation.
Neutral
GlobeNewsWire
about one month ago
TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), is pleased to announce that national television network CTV News' flagship investigative program W5 will air, starting today, a three-part series about Quantum Biopharma and the company's allegations of stock market manipulation.
More FSD Pharma Inc News

Company Profile

FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. FSD Pharma Inc. has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products; and collaborative research and development agreement with Solarvest BioEnergy Inc. The company is headquartered in Cobourg, Canada.

Head office Canada
CEO Zeeshan Saeed
Founded 1994
Website www.quantumbiopharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today